Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

532 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB).

NCT00435825

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • San Diego, California, United States
  • San Francisco, California, United States
View all 55 locations
View Trial Details
Completed

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

NCT01708889

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +16 more
Locations
  • Clinical Pharmacology Of Miami Inc. Miami, Florida, United States
  • Orlando Clinical Research Center Orlando, Florida, United States
  • New Orleans Center For Clinical Research - Knoxville Knoxville, Tennessee, United States
View Trial Details
Completed

Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.

NCT00298363

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Pfleger Liver Institute Los Angeles, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
  • University of Miami, Center for Liver Diseases Miami, Florida, United States
  • Rush Presbyterian - St. Luke's Medical Center Chicago, Illinois, United States
View all 38 locations
View Trial Details
Completed

Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a

NCT00199732

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Service d'Hépato-gastroentérologie Limoges, France
  • Service de Médecine Interne Limoges, France
  • Service de Virologie Limoges, France
  • Service des Maladies Infectieuses et Tropicales Limoges, France
View Trial Details
Completed

Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B

NCT00410072

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Sergio E. Rojter Los Angeles, California, United States
  • Tuan Nguyen, Md San Diego, California, United States
  • San Jose Gastroenterology San Jose, California, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
View all 68 locations
View Trial Details
Completed

Suboptimal Responders to Adefovir Switching to Entecavir

NCT00718887

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Local Institution Beijing, Beijing Municipality, China
  • Local Institution Guiyang, Guizhou, China
  • Local Institution Nanjing, Jiangsu, China
  • Local Institution Nanchang, Jiangxi, China
View Trial Details
Completed

Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

NCT01143662

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • 302 Military Hospital Beijing, China
  • Beijing Youan Hospital, Capital Medical University Beijing, China
  • Beijing Youyi Hospital, Capital Medical University Beijing, China
  • Peking University First Hospital Beijing, China
View all 39 locations
View Trial Details

Related conditions